Featured Editorial

  1. Why Clinical Supply Teams Need To Understand CDISC 7/29/2026

    CDISC standards are reshaping clinical trial operations. Learn why supply teams must align physical inventory, trial data, and regulatory requirements to avoid costly delays.

  2. The Hidden Cost Of Poor Data In Global Supply Chains 7/29/2026

    Poor data does more than create reporting errors. Learn how misaligned RTSM, ERP, and depot systems drive inventory risk, delays, higher costs, and manual work.

  3. The Hidden Cost Of Convenience: Single-Use Supply Chain Vulnerabilities And Clinical Trial Continuity 7/28/2026

    Single-use technologies improve flexibility, but overreliance on single suppliers can jeopardize trial continuity. Learn how to build resilience before disruptions occur.

  4. Reshoring Pressure Meets Manufacturing Reality 7/27/2026

    U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.

  5. CDMO Live Europe 2026: Partnerships For An Uncertain World 7/27/2026

    112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.

  6. Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report 7/27/2026

    Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.

  7. The Fragility Of Efficiency: Why Global Clinical Supply Chains Fail In An Era Of Geopolitical Fragmentation 7/27/2026

    Global disruptions are exposing weaknesses in clinical supply chains. Learn practical strategies to build resilience, reduce waste, and protect trials from costly delays.

  8. Annex 22 Is Not A Brake On AI. It Is The Framework Clinical Supply Has Been Waiting For 7/24/2026

    EU GMP Annex 22 provides a practical framework for adopting AI in clinical supply, helping teams validate forecasting, planning, and decision support with confidence.

  9. South Africa In Clinical Trial Supply: An Underrecognized Capability 7/23/2026

    Many sponsors still plan for South Africa using outdated assumptions. Learn how current regulatory, logistics, and supply capabilities support reliable clinical trial execution.

  10. How Early Signals Prevent Risk In Clinical Trial Supply Chains 7/22/2026

    Small shifts in forecasts, RTSM behavior, and inventory can reveal future supply risks. Learn how early signals help clinical teams prevent disruptions before they escalate.